Market Research Blog

[296 Pages Report] Increase In awareness regarding advanced skincare products and rising prevalence of chronic diseases are expected to drive skincare market. According to a study by Future Market Insights (FMI), the global skincare market is forecast to reach a valuation of US$ 8,823.4 Mn in 2021.

The rising prevalence of several infectious diseases has necessitated innovation in the skincare market. According to the World Health Organization (WHO), the prevalence of chronic diseases was expected to increase by 57.0% by 2020, which indicated that a significant percentage of the population would suffer from chronic ailments. Also, the global outbreak of pandemics such as H1N1, Ebola, and others are boosting the requirement of different hand and skin hygiene products such as hand sanitizers, which is indicative of growth opportunities for the market.

Request Sample Copy of Report: @ https://www.futuremarketinsights.com/reports/sample/rep-gb-13122

Skincare products such as skin cleansers, hand sanitizer, skin conditioners, and surgical scrubs are increasingly used to maintain skin hygiene and to prevent the spread of infections. The rising prevalence of chronic diseases and increase in demand for hand sanitizers amid COVID-19 pandemic is expected to boost the growth of the skincare market.

Moreover, increasing incidence of hospital-acquired diseases such as surgical site infection (SSI) is creating opportunities for growth. Sales will surge further as a result of the increasing awareness about advanced skincare products. Social media & innovative online campaigns aimed at creating awareness are therefore reshaping the skincare market.

Increasing market consolidation activities, adoption of strategic agreements among the leading manufacturers and increasing research activities aimed at launching effective products are some of the factors enabling growth. Some of the leading players are aiming to strengthen their product portfolio by launching a various online campaign. For instance, in 2021, Galderma Laboratories, L.P.-Cetaphil launched an innovative digital campaign to connect with millions of consumers experiencing skin sensitivity.with the market expected to exhibit a CAGR of 8.1% during the forecast period (2021-2031)

Ask from the Market Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-13122

Key Takeaways from Skincare Market Study

Skincare market is expected to rise at 8.1% CAGR between 2021 and 2031
High willingness among consumers to spend on personal health and hygiene will drive growth in the U.S., which will account for over 85% of sales in North America by 2031
The U.K. will remain a key market for skincare products within Europe. Rising demand from various hospitals, healthcare, and critical care centers will continue supporting growth
Expansion of the healthcare sector will push growth in Germany, which will account for maximum skincare products sales within Europe’s healthcare sector
Strong growth is likely in China, as consumers increasingly focus on hygiene and sanitization to prevent the risk of infection

Key Players :

• 3M Company
• Cardinal Health, Inc.
• Ecolab
• Whiteley Corporation
• Reckitt Benckiser Group PLC
• Carrollclean
• Johnson & Johnson Consumer Inc.
• Galderma laboratories, L.P.
• PDI, Inc.
• Betco Corporation
• Pal International
• PSK Pharma Pvt. Ltd.
• Metrex Research, LLC.
• Gojo Industries, Inc.
• Unilever
• Steris Plc.
• Procter & Gamble

Buy this report @ https://www.futuremarketinsights.com/checkout/13122

Skincare Market by Category

Product

• Skin Cleansers
• Hand Sanitizers
• Surgical Scrubs
• Skin Conditioners
• Other

Form

• Liquid
• Gel & Lotions
• Wipes
• Spray & Foams

End-user

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Diagnostic Laboratories
• Reference Laboratories
• Rehabilitation Centers
• Long Term Care Centers
• Critical Care Centers
• Pharmaceutical & Biotechnology Companies
• Academics and Research Institutes
• Homecare Settings

Region

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• The Middle East and Africa (MEA)

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

[250 Pages Report] Future Market Insights (FMI) has forecast positive outlook for the nasal spray market in a recent study. The rising cases of allergic rhinitis and the demand for better accuracy in drug delivery are identified as chief growth drivers. Growth is expected to remain bullish as various countries showcase high healthcare spending.

Nasal Spray Market is expected to expand at a moderate CAGR of over 6.1% over the next ten years, and be valued at more than US$ 3.21 Bn by 2030-end. As per product, the demand for nasal steroid spray will remain considerably high, accounting for the leading share in the market though the course of the forecast period.

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-13112

The global dental tourism market is primarily driven by increasing cases of dental defects and an increasing preference for cosmetic dentistry worldwide. Lower treatment price and better service in dental treatment abroad, long waiting times at home for dental treatment can stimulate the growth of the market in the near future. Dentist malpractice is likely to hold back the market during the forecast period.

The global dental tourism market is expected to reach a valuation of US$ 6.7 bn in 2022, with sales growth of a 13.6% CAGR during the forecast period. Rapid adoption of technologically advanced medical devices in emerging economies will drive the growth in the market, with the market size reaching € 24.3 bn by 2032.

Rising costs of health care and dental services in developed countries are forcing consumers to adopt dental tourism. This trend is driven by the lack of insurance coverage for major elective dental surgery procedures in several countries.

Get Sample Report@  https://www.futuremarketinsights.com/reports/sample/rep-gb-14623

In addition, treatment costs in countries such as India, Thailand and China are relatively lower than in the countries of North America and Europe. This reflects an increase in dental tourism from Europe and North America to emerging economies. Obtaining a medical visa for such procedures is comparatively faster and easier, thereby facilitating the flow of patients abroad for treatment.

Promotional strategies such as the launch of online campaigns showcasing cost-effective services from healthcare facilities are contributing to the growth of the market. Providing undivided attention to healthcare and providing affordable accommodation sparks consumer interest in adopting attractive medical-tourism packages, identifying both treatment and recreational choices.

As per Future Market Insights’ latest industry analysis, the U.S. animal model market was valued at over US$ 921.9 Mn in 2021 and is anticipated to exhibit a CAGR of close to 4.1% over the forecast period (2022-2032).

Animal models are predominantly used to gather information regarding the disease and its prevention, diagnosis, and treatment. They are being used to resolve a wide range of scientific concerns, ranging from basic science to the discovery and evaluation of new vaccines and therapies. Animals are used because of the similarities in biology across most mammals.

Get Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14527

Personalized medicine is also known as precision medicine which utilizes data about a specific patient or an individual’s genes to plan treatment for a disease. Animal models can play important role in the development of new approaches for personalized medicine. Increasing adoption of personalized medicine will drive sales of animal model in the forthcoming years.

Toxicity testing in animals is done to discover potential side effects from an agent’s exposure and to generate dose-response relationships. Animal testing is important for the early detection of the potential risk to humans or as models to study the causes, pathogenesis, progression, and treatment of diseases.

Organizations and legislations such as the Federal Food, Drug, and Cosmetic Act (FFDCA), Environmental Protection Agency (EPA), Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), and Organization for Economic Co-operation and Development (OECD) determine the testing guidelines for toxicity testing on animals.

Some factors such as the high production volume of chemicals testing in the U.S., increasing generation and utilization of novel GM animal strains in toxicity studies, and the development and attempted validation of several animal tests to screen chemicals for endocrine (hormone)-disrupting activity are expected to drive the growth in the market.

For in-depth insights, Download a PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-14527

Key Takeaways:

• Based on species, the mice model segment is expected to hold nearly 62.6% of the total market share 2022, with sales growing at a 5.1% CAGR.
• In terms of therapeutics, the oncology accounted for more than 32.0% of the total market share in 2021, and the trend is expected to continue over the forecast period.
• By application, sales in the drug discovery/development segment commanded 65.4% of the total market share in 2021.
• Based on end user, the academic & research institutes segment accounted 36.6% of the total market share in 2021.

Key Players:

• Charles River Laboratories
• The Jackson Laboratory
• Taconic Biosciences, Inc.
• Genoway
• Envigo (Inotiv, Inc.)
• Marshall BioResources
• Janvier Labs
• Applied stem cells
• Biocytogen
• Transposagen Biopharmaceuticals, Inc. (Hera Bio Labs)
• Cyagen
• Ingenious targeting labs
• Crown Bioscience Inc. (JSR Corporation).
• Harbour Biomed
• Sinclair Bio Resources
• Alpha Genesis Inc.
• Creative Animodel
• DaVinci Biomedical Research Products, Inc

For in-depth competitive analysis, Buy Now @ https://www.futuremarketinsights.com/checkout/14527

Market Competition

Key players operating in the U.S. animal model market are expanding their business through partnerships and acquisitions with other companies to improve their global footprint. Following are a few examples of acquisitions:

• In October 2021, The Jackson Laboratory completed the acquisition of Charles River Laboratories Japan’s Research Models & Services (RMS), which allows advancement in the company’s scientific improvements in basic research and drug discovery.
• In November 2021, Inotiv, Inc., which is a leading contract research organization (CRO) completed its acquisition of Envigo RMS Holding Corp. to expand its R&D sector.
• In February 2021, Biocytogen completed the acquisition of a third Beacon Optofluidic system. This acquisition expanded Biocytogen’s service platform in the Boston area.

What Does the Report Cover?

Future Market Insights offers a unique perspective and actionable insights on the animal model market in its latest study, presenting a historical demand assessment of 2017–2021 and projections for 2022– 2032.

The research study is based on the species – (rats, mice, pigs, rabbits, monkeys, dogs, cats, other species), therapeutics- (metabolic diseases, cardiovascular diseases, neurological diseases, and oncology), application (drug discovery/development and basic & applied research) end-user (academic & research institutes, pharmaceutical companies, biotechnology companies, and CROs) and across seven key regions of the world.

Future Market Insights’ Expertise in Life Sciences and Transformational Health

Our expert team of industry analysts comprising management graduates, medical professionals, engineers, and project managers provides insights on emerging therapy areas, diagnostic tools, medical devices and components, reimbursement and market access, biotechnology, and life science research products and services to equip decision-makers with sound inputs and strategic recommendations.

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports : https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

Valuable insights on the global scenario of microscope digital cameras have been presented systematically in a recently carried out research on microscope digital cameras market by Future market Insights in its new publication titled “Microscope Digital Cameras: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2027)”. This research focusses on key players, trends, growth drivers, opportunities, developments and restraints across several key geographies of North America, Western Europe, Eastern Europe, Asia Pacific excluding Japan (APEJ), Latin America, Japan and Middle East and Africa (MEA). On the basis of a structured research process and taking into consideration the past and present scenario, forecasts are provided in the research report from the period 2017 to 2027, a ten year forecast model, across each and every segment of the market.

Global Microscope Digital Cameras Market: Competition Analysis

The global microscope digital cameras market has profiled key players such as Danaher Corporation, Nikon Corporation, Roper Technologies, Inc., Carl Zeiss AG, Olympus Corporation, Hamamatsu Photonics K.K, Basler AG, Guangzhou Micro-shot Technology Co., Ltd., BMS microscopes bv., and Euromex Microscopen bv.

Get a Sample Copy of the Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-3523

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Increasing prevalence of sleep disorders, especially in the U.S. and other European countries, creates lucrative growth opportunities for the sleep testing respiratory devices market. According to the National Healthy Sleep Awareness Project, around 25 million adults in the U.S. were suffering from sleep apnea.  Continuous focus on the market introduction of technologically advanced respiratory devices such as nebulizers, pulse oximeters and spirometers is expected to drive the respiratory devices market growth during the forecast period.

Rising prevalence of chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea has been increasing the demand for respiratory devices. Future Market Insights (FMI) in a new study has forecast the market to continue exhibiting high demand through 2031. While 2020 has proven exceptionally crucial to the market, growth will remain positive 2021 onwards, despite declining a little in comparison to remarkable sales recorded in 2020 amid COVID-19 outbreak.

Growing preference for smart or wearable respiratory devices over general respiratory devices in developed countries also creates a significant opportunity for global market players operating in the respiratory devices market. Adoption of portable devices for neonatal and adults suffering respiratory diseases is growing respiratory devices demand. For instance, Patients suffering from chronic respiratory diseases require continuous oxygen supply. A portable oxygen concentrator has several other benefits such as lightweight, small shape and easy to carry, which makes it the best choice of device.

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-794

Hospitals are likely to remain chief end users of respiratory devices. They have been relentlessly offering patient care amid COVID-19 outbreak. Even as numbers of COVID-19 patients soared, healthcare centers around the world pushed through challenges to offer required care. Hospitals therefore accounted for a little above 40% of respiratory devices sold in 2020. By 2031, the number of respiratory devices sold in hospitals is expected to rise further.

Key Takeaways of Respiratory Devices Market Study

• Respiratory devices market will exhibit impressive growth through 2031. The market is forecast to exhibit 9.3% CAGR in 2021
• S. will remain the most lucrative market, accounting for almost 87% of respiratory devices sold in North America
• UK will exhibit impressive Y-o-Y growth at 10.5% in 2021
• Germany and France will continue exhibiting high demand for respiratory devices
• China and Korea will remain bright spots in East Asia market, however, Japan will remain dominant through the forecast period

Partnerships to Develop New Products – Imperative Strategy for Market Players

Leading manufacturers of the respiratory inhaler are focusing on strategic partnerships with software and digital companies to serve the selected population. Besides, such collaborations also help manufacturers improve their distribution channels as well as to launch their products. For instance, In June 2020, Medtronic plc entered into a partnership with Foxconn Industrial Internet to begin manufacturing Medtronic’s Puritan Bennett 560 (PB560) ventilators in the United States.

Similarly, Smith’s Medical has signed a distribution partnership with Medline Industries for distribution of the Portex acapella, a vibratory PEP therapy device to focus on the non-acute and home care channels in 2019.

Ask from the Market Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-794

Key Segments

Product

• Respiratory Consumables
  • Respiratory Mask
  • Nasal Cannulas
  • Oxygen Tubing Sets
  • Breathing Filters
• Nebulizers
  • Compressed Jet Nebulizers
  • Ultrasonic Nebulizers
• Oxygen Concentrators
  • Home Oxygen Concentrators
  • Portable Oxygen
  • Concentrators`
• Positive Airway Pressure (PAP) Devices
• Polysomnography Devices
  • Ambulatory PSG Devices
  • Clinical PSG Devices
• Pulse Oximeters
• Mechanical Ventilators
• Spirometers

Download PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-794

End Users

• Hospitals
• Ambulatory Surgical Centers
• Clinics
• Long Term Care Centers
• Others

Region

• North America
• Latin America
• Europe
• East Asia
• South Asia
• The Middle East and Africa (MEA)
• Oceania

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

[250 Pages Report] Sales of global manometry systems are expected to reach US$ 157.3 Mn in 2020. As per Future Market Insights, revenues for manometry systems are expected to reach US$ 279.6 Mn, expanding at a 5.4% CAGR over the forecast period (2021-2031).

Rise in number of people aged 65 years and older is expected to be the major factor boosting the growth of the manometry system market. In 2018, According to the U.S. Census Board people older than 65 years represent around 13% of the total population; this percentage is expected to reach 20% by 2031.

Rising cases of constipation, fecal incontinence, anorectal pain, pelvic floor dyssynergia and hirschsprung’s among older population is increasing the adoption of manometry systems. Demand for these systems helps evaluate patients and provides many useful data regarding anorectal function and indicates the prognosis of treatment, particularly in the management of sphincter injuries.

Get Sample Report@  https://www.futuremarketinsights.com/reports/sample/rep-gb-14110

Rising demand for non-invasive equipment is driving the demand for manometry system. These systems are non-invasive diagnostic procedure that can detect pressures and sensation in the anus and rectum. With this, they indicate whether the patient’s pelvic function is normal without incision into the body or removal of tissue and has low risks, and complications.

Further, rising government initiatives and funding supporting the development of product is boosting the demand for manometry system market.  Initiatives undertaken by government to enable and boost the ecosystem for the indigenous medical device industry is also stimulating market growth.

“As demand for manometry systems is rising due to high prevalence of gastrointestinal diseases, key players are engaging in product development that is technologically advanced for faster approvals. This is expected to give the key players a competitive edge in the industry, generating revenues,” says the FMI Analyst

Key Takeaways from Manometry System Market Study

• By product, system sheath & catheters is expected to account for the largest share of 55.0% in 2021.
• In terms of portability, stand-alone system will hold for the largest share of 55.4% in 2021 on the back of its enhanced sensitivity to provide accurate diagnosis of condition
• By end user, hospitals accounted for the largest share of 37.9% in 2021 owing to the rising demand for hospital stay that is short-term and increasing number of gastrointestinal processes.
• North America is expected to hold largest share of 38.9% in 2021 with the U.S. leading the market during the forecast period.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-14110

Who is Winning?

Some of the leading manufacturers of manometry system market are focusing on product launch collaboration and partnership strategies for global expansion objectives, thereby, enhancing their market presence.

Several joint ventures, agreements, and loan licensing procedures have influenced the market. The government of developing economies has taken several reforms to develop the market by regulating it to bring out more transparency and by allowing foreign investments in the industry.

New Product launches & approvals have emerged as key growth strategy adopted by the leading players in the manometry system market. Followed by this, acquisition was the second most key strategy adopted by the industry players. By adopting these strategies, it helped the company to expand their regional presence as well as product offerings.

For instance,

• In October 2021, “UROTECH GmbH subsidiary of Medi-Globe Group’s provided detailed information on a new clinical study for using the Magnetic Black-Star® (MBS) in paediatric urology. The MBS was an innovative product of the UROTECH GmbH, which is used in stent placement as well as stent removal of children by without performing the surgeries using the stent’ magnetic tip.”
• In May 2020, RMS Medical Devices, proudly announced it’s the acquisition of QUICKORE products for BENELUX. With this new acquisition, RMS Medical Devices adds another premium technology to its Radiology portfolio.
• In October 2020, LABORIE Medical Technologies enters into strategic partnership with Urotronic to support regulatory approval of Optilume™, a drug-coated balloon (DCB) technology for use in urethral strictures and benign prostatic hyperplasia (BPH).

• In August 2021, Medtronic Announced the FDA Approval of Next-Gen TAVR System for the treatment of symptomatic severe aortic stenosis. Next-Gen TAVR System is a self-expanding transcatheter aortic valve replacement, which is designed to enhance ease-of-use and predictable valve deployment throughout the procedure.

The key market players covered by FMI include EB Neuro S.p.A, MEDSPIRA, Medtronic, Medica S.p.A., RMS Medical Devices, MARQUAT Génie Biomédical, Diversatek Inc., Dentsleeve International Ltd., LABORIE, Prometheus Group, Smart Medical Group, Synectics Medical Limited, Medovations Inc., Sierra Scientific, and Urotech Gmbh.

Manometry System by Category

Product:

• Anorectal Manometry System
• Anorectal Manometry System Software
• Anorectal Manometry System Sheath & Catheters

Portability:

• Stand Alone System
• Portable System

End User:

• Hospitals
• Diagnostic Centers
• Speciality Clinics
• Academic Research Institutes

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

According to a recent study by Future Market Insights (FMI), sales of home infusion therapy devices are expected to top US$ 2.0 Bn in 2021, growing at a CAGR of over 6.5% during the forecast period (2021-2031).

Home infusion therapy devices are used for the intravenous administration of medicines. It is commonly prescribed for patients with serious infections and specialized diseases when orally administered medicines are not or comparatively less effective.

Application of home infusion therapy devices is increasing with the rising number of surgeries conducted across the globe. Post-surgery pain management at home can be done with the help of home infusion therapy devices.

Besides this, rising healthcare expenditure and growing awareness regarding the risk and infection amidst the outbreak of COVID-19 is driving the demand of home infusion therapy devices.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-13974

Key Takeaways from Home Infusion Therapy Devices Market Study

• By product type, infusion system accessories will hold around 45% of value share globally.
• Based on the application, antibiotic administration is leading with over 34% of the market share.
• Home care settings sales will dominate the home infusion therapy devices, with a market share of 65% during the forecast period.
• By region, the U.S. will dominate the global home infusion therapy devices market with a value share of around 37% during the forecast period.
• Followed by North America, Europe will be the second-largest leading region, with a value share of 93.2% during the forecast period.
• India is the dominant country in term of revenue for South Asia Home infusion therapy devices market, accounting for nearly 48% of market share in 2021.
• China holds leading position in East Asia and is expected to account for nearly 52% of market share.

“Growing prevalence of chronic diseases such as diabetes and cancer in the midst of COVID-19 pandemic and high risk of infection across hospitals encouraged key players to invest in new product launches. This is expected to enable growth in the market in the coming years” says a FMI Analyst.

Who is Winning?

Key players are focusing on new product launches and approvals. Other growth strategies adopted by leading players include, agreements, and collaborations among key manufacturers. By focusing on these strategies, key players are expanding their geographic presence and strengthening their existing product portfolio.

For instance,

• In June 2019, Baxter International Inc. announced that Myxredlin that is the first and only ready-to-use insulin for IV infusion get the US FDA approval.
• In Jan 2019, Fresenius Kabi AG launched two colourful bags via white spiral cables to supply the nutrient solution for parenteral nutrition.
• In April 2017, B. Braun Melsungen AG announced the launch of home infusion therapy App named Easypump® for healthcare professionals and patients.

The key market players profiled by FMI include Becton, Diciknson & Company, B.Braun Melsungen AG, Baxter International, Fresenius Kabi, Terumo Corporation, ICU Medical, Nipro Corporation, Smiths Medical, Micrel Medical Devices SA, Moog Inc., JMS Co.Ltd., Intera Oncology, and Others Top-up.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-13974

Home Infusion Therapy Devices Market by Category By Product Type:

• Disposable Elastomeric Pumps
• Insulin Pumps
• PCA Pumps
• Electronic Ambulatory Pumps
• Infusion System Accessories

By Applications:

• Enteral Nutrition
• Parenteral Nutrition
• Chemotherapy
• Antibiotic Administration
• Others

By End User:

• Home Care Settings
• Long Term Care Centers

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

[269 Pages] According to Future Market Insights (FMI) the worldwide yearly tracker, vendor revenue in global biological & chemical indicators market will grow 9.1% year over year to 396.8 Mn in 2020. Global shipments will rise 9.7% year over year to 830.7 Mn units in 2020.

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 8-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

According to a recent study by Future Market Insights (FMI), the global intraosseous (IO) infusion devices is expected to witness high growth during the forecast period. The market is expected to grow from US$ 3.5 Bn in 2020 to over US$ 7.9 Bn by 2031. It will therefore register CAGR of around 7.6% over the forecast period (2021-2031).

The increasing number of emergency cases has been propelling the market growth. These cases include strokes, seizures, burns, sudden breathing difficulty, and other health concerns where the use of intraosseous infusion devices is of immense need. Intraosseous infusion devices come into practice when intravenous entry points are unavailable and so treatment is provided through an entry point on the bone marrow.

Get a Sample Copy of the Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1569

Intravenous fluid and drug administration is a prime choice in the normal medical procedure as they are comparatively economic and less painful than intraosseous infusion. However, demand for intraosseous infusion is expected to increase on the back of the rise in the need for rapid and high volume infusions during an emergency.

Market Outlook:

The recent articles posted by CDC in September 2021, states that heart diseases are the leading cause of death which means 659,000 people in the United States die due to heart diseases. This is due to lifestyle changes, cardiac arrest and cardiovascular surgery which are getting common globally with an incidence rate of around 0.7 to 2.9%.

Defibrillation is the primary resort for cardiac arrest for resuscitation on the failure of which titrated adrenaline is administered through the sternum using an intraosseous infusion device. The rising prevalence of cardiovascular disorder is expected to fuel the demand for IO infusion device market

Healthcare companies are constantly collaborating with healthcare professionals, healthcare service providers, and hospitals to improve quality care for the patients.  Thus, delivering high quality care together with advanced technologies, which will further drive the overall market in the forecast period.

June 1, 2020, Becton, Dickinson and Company, acquired acquisition of Straub Medical AG which develops and sells medical atherectomy and thrombectomy devices that treat peripheral arterial disease (PAD) and venous disease. This helped BD explore advancing technologies driving the market.

Currently, the COVID-19 pandemic has changed the opinions and many companies and Governments are indulging themselves in investing in the intraosseous infusion market. This change has driven the market to the next level. In addition, COVID-19 has been a great aperture in exploring one’s business into healthcare. Government is funding companies in improving healthcare infrastructure.

To increase revenue share, the hospitals are focusing on increasing investment in research and development. It is thus, expected for market players to enjoy the lucrative growth of the investing in intraosseous infusion market in the forecast period.

Such developments not only strengthen the company’s existing portfolio but also help to increase their presence at the regional as well as global level, and help companies to sustain the increasing competitive pressure.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-1569

Key Takeaways from Intraosseous Infusion Devices Market Study

• By product, EZ-IO holds the maximum share of 21.4% in the market in 2021, expanding at 7.6% CAGR during the forecast period.
• By route of administration, the sternum segment will account for 30.8% of the market share in 2021, indicating the highest demand.
• By technology, the automatic segment will account for more than 50% of the market share in 2021.
• By end user, EMS centers and Hospitals together account for more than 60% of the market share in 2021.
• By region, North America holds the largest share of 26.6% of the global intraosseous infusion devices market in 2021.

“Increasing demand in improving standards of pre-hospital emergency care settings will boost the intraosseous infusion devices market over the decade. Growth will continue as market players focus on automation to improve the overall quality of devices,” says a FMI Analyst

Who is winning?

Some of the leading companies operating in the intraosseous infusion device market are focusing on product launch, collaboration, and partnership strategies.

• In January 2015, Teleflex, Inc. Company acquired all common stocks of Human Medics Co., Ltd., a South Korea-based distributor of surgical and respiratory products. – This is expected to favour the distribution network of the company in South Korean market
• In June 2015, Teleflex, Inc Company acquired certain assets of N. Stenning & Co. Pty. Ltd. – a medical device distributor and supplier based in Australia. – This is expected to support the distribution and penetration of the company’s products in Australia.

The key market players covered by FMI include

• Pyng medical Corp.
• Cook Medical Incorporated
• PerSys Medical
• Aero Healthcare
• Teleflex, Inc.
• Becton Dickinson and Co..

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-1569

Intraosseous Infusion Devices – Market by Category

Product:

• B.I.G
• FAST1
• EZ-IO
• FASTR
• IO Needles
• Others

By Route of Administration:

• Sternum
• Distal & Proximal Tibia
• Distal Femur
• Calcaneus
• Head of Humerus

By Technology:

• Manual
• Automatic
  • Impact Driven
  • Power Drill

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs